Sleep Disorders treatments
Explore information about Sleep Disorders. An independent doctor decides whether a prescription is appropriate. Dispensing and delivery depend on a valid prescription, the available route and an independent licensed pharmacy.
Choose a treatment to review
Pricing is indicative where shown. Final route, fulfilment, and whether treatment is clinically appropriate remain subject to independent doctor review. Check platform, independent doctor, pharmacy and delivery charges before payment. A listed medicine amount is not a complete route quotation.
About sleep disorder treatments
Sleep disorders represent a significant and growing public health burden across the European Union. Insomnia — characterised by persistent difficulty falling or staying asleep, or waking too early and being unable to return to sleep, with consequent daytime impairment — is estimated to affect between 10% and 30% of the adult European population. When accounting for sub-threshold sleep disturbance, the figure is considerably higher.
The consequences of inadequate sleep extend well beyond fatigue. Chronic insomnia is associated with increased risk of cardiovascular disease, metabolic disorders including type 2 diabetes, depression, anxiety, and impaired cognitive function. Occupational and road safety risks associated with sleep deprivation impose significant societal costs.
Sleep disorders exist on a spectrum. Transient or short-term insomnia, often related to stress, travel, or life events, frequently resolves without pharmacological intervention. Chronic insomnia — defined as occurring at least three nights per week for at least three months — is a recognised medical condition warranting clinical evaluation and, where appropriate, treatment.
International clinical guidelines, including those from the European Sleep Research Society, recommend cognitive behavioural therapy for insomnia (CBT-I) as the first-line treatment for chronic insomnia. Pharmacological treatments may be appropriate for short-term management or when CBT-I is unavailable or insufficient. Prescription sleep medications include melatonin (approved for certain indications), and sedative-hypnotic agents (Z-drugs) such as zopiclone and zolpidem.
It is important that any prescription for sleep medication be accompanied by assessment for underlying causes, including sleep apnoea, depression, anxiety, or medication side effects. A qualified, independent doctor is best placed to determine the appropriate treatment pathway.
Available treatments
The following medications are described here for sleep disorders. Independent doctors make prescribing decisions. Licensed pharmacies dispense only where approved and available. This comparison is provided for informational purposes only.
| Medication | Active Ingredient | Class | Typical Use |
|---|---|---|---|
| Melatonin (prescription) | Melatonin | Chronobiotic hormone | Circadian rhythm disorders, older adults with insomnia |
| Zopiclone | Zopiclone | Z-drug (sedative-hypnotic) | Short-term insomnia |
| Zolpidem | Zolpidem tartrate | Z-drug (sedative-hypnotic) | Short-term insomnia |
Key distinctions:
- Melatonin: A physiological hormone rather than a sedative. Primarily regulates circadian rhythm. Circadin is authorised for short-term primary insomnia in patients aged 55 or over; this authorisation does not cover jet lag. Lower dependence risk than Z-drugs.
- Zopiclone: A cyclopyrrolone that enhances GABA activity, producing sedation. Standard prescription duration is typically 2–4 weeks. Carries risks of tolerance, dependence, and morning residual sedation.
- Zolpidem: An imidazopyridine with similar mechanism to zopiclone. Sleep-onset focused. European regulators strengthened warnings about next-morning impairment; the EU review did not introduce a lower recommended dose specifically for women.
How to get sleep disorder treatment online
Prescrivia operates as a technology intermediary. We do not prescribe medications, employ doctors, or sell medicines. Our platform collects your health assessment for review by an independent licensed prescriber.
The process:
-
Complete a health assessment — Answer a structured set of medical questions covering your sleep patterns, duration of difficulties, sleep environment, mental health history, current medications, and any previous treatment for sleep disorders.
-
Independent doctor review — An independent doctor reviews your assessment. If a prescription sleep medication is clinically appropriate for a short-term period, the doctor may issue a prescription. If other factors indicate a different approach is warranted, the doctor will advise accordingly.
-
Pharmacy fulfilment — A valid prescription does not guarantee dispensing or delivery. An independent licensed pharmacy checks lawful supply, stock and an available supply route for the destination country.
Important: Prescrivia does not guarantee that a prescription will be issued. Prescribing decisions are made entirely by independent medical professionals. Z-drugs are controlled substances in many EU member states and are subject to strict prescribing restrictions.
How we compare
| Through Prescrivia | In-person GP appointment | |
|---|---|---|
| Availability | Online assessment, subject to platform availability | Subject to appointment availability |
| Wait time | Review time depends on clinical needs and availability | Depends on appointment availability |
| Travel required | No | Yes |
| Prescribing decision | Made by independent doctor | Made by your GP |
| Ongoing monitoring | Supported via follow-up assessments | Managed by your GP |
| Cost | Transparent pricing displayed upfront | Varies by country and healthcare system |
Note: Sleep disorders associated with sleep apnoea, restless legs syndrome, narcolepsy, or significant psychiatric comorbidity require specialist evaluation. Prescrivia’s platform is designed for adults with primary short-term insomnia suitable for remote assessment. Long-term management of chronic insomnia should ideally involve CBT-I delivered by a qualified practitioner.
Sources
Medical information on this page is based on the following sources:
- European Medicines Agency (EMA). Circadin (melatonin) — Summary of Product Characteristics. Available at: ema.europa.eu
- Riemann D, et al. European guideline for the diagnosis and treatment of insomnia. Journal of Sleep Research. 2017;26(6):675-700.
- World Health Organization (WHO). Sleep and health — WHO Fact Sheet. who.int
Medical information may change as clinical guidance is updated. It is provided for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for advice relevant to your individual health circumstances.
Availability, dispensing and delivery depend on the country, clinical assessment, pharmacy and applicable law. A Spanish-language page does not establish eligibility for supply in Spain.
Frequently asked questions
- How does an online assessment for sleep medication work?
- Yes. Through Prescrivia, you can complete a health assessment reviewed by an independent doctor. Where a prescription sleep medication is clinically appropriate, the doctor may issue a prescription. A pharmacy may dispense after confirming a valid prescription, applicable requirements, stock and availability for the destination. Dispensing and delivery are not guaranteed.
- What is the difference between melatonin and zopiclone or zolpidem?
- Melatonin is a hormone naturally produced by the body that regulates the sleep-wake cycle. Prescription melatonin is primarily used for circadian rhythm disturbances and jet lag, and for older adults with insomnia. Zopiclone and zolpidem are sedative-hypnotic drugs (Z-drugs) that act on GABA receptors to induce sleep. They are more potent and carry greater risk of dependence.
- How long can I take zopiclone or zolpidem?
- Z-drugs such as zopiclone and zolpidem are generally recommended for short-term use only — typically 2 to 4 weeks — due to risks of tolerance, dependence, and withdrawal. European clinical guidelines recommend cognitive behavioural therapy for insomnia (CBT-I) as the first-line treatment for chronic insomnia.
- Is melatonin available without a prescription in Europe?
- Melatonin's regulatory status varies across EU member states. In some countries it is available as an over-the-counter supplement; in others, including Germany and Ireland, prescription-strength melatonin requires a doctor's prescription. An independent doctor can assess what is appropriate for your situation.
- What information do I need to provide for a sleep disorder assessment?
- You will typically be asked about the nature of your sleep difficulties, how long they have persisted, any identified triggers, your current medications, medical history (including mental health history), and whether you have been evaluated for conditions such as sleep apnoea. This allows the reviewing doctor to make a safe clinical decision.
Intermediary notice: Prescrivia connects patients with independent doctors and licensed pharmacies. We do not provide medical advice, employ doctors, or sell medicines. All medical decisions are made by independent healthcare professionals, and prescription-only medicines require a valid prescription. Treatment is not guaranteed — whether a prescription is issued depends on an independent doctor's clinical assessment.
Ready to begin your assessment?
Complete a short health assessment and, where clinically appropriate, connect with an independent doctor for review.
Prescrivia is not a doctor or pharmacy — it is a technology platform. Any prescription decision is made by an independent doctor; medicines are dispensed by licensed pharmacies only where available.